Literature DB >> 18769882

Significance of stereochemistry of 3'-terminal phosphorothioate-modified primer in DNA polymerase-mediated chain extension.

Barbara Nawrot1, Natasha Paul, Beata Rebowska, Wojciech J Stec.   

Abstract

Influence of stereochemistry of the 3'-terminal phosphorothioate (PS)-modified primers was studied in a single base extension (SBE) assay to evaluate any improvements in specificity. SBE reactions were catalyzed by members of the high fidelity Pfu family of DNA polymerases with (exo+) or without (exo-) 3' --> 5' exonucleolytic activity. The diastereomerically pure PS-labeled primers used in these studies were obtained either by the stereospecific chemical synthesis invented in our laboratory or by the more conventional ion-exchange chromatographic method for separation of a mixture of diastereomers (R(P) and S(P)). When the SBE reaction was performed in the presence of mispaired 2'-deoxyribonucleoside triphosphates (dNTPs), the "racemic" 3'-phosphorothioate primer mixture resulted in a lower level of 3' --> 5' exonuclease-mediated cleavage products in comparison to the SBE reactions carried out with the corresponding unmodified primer. When the diastereomerically pure RP 3'-phosphorothioate primer was examined, the results were largely the same as for the racemic 3'-phosphorothioate primer mixture. In contrast, a 3'-PS primer of S(P) configuration displayed significantly improved performance in the SBE reaction. This included the lack of 3' --> 5' proofreading products, less mispriming, and improved yield of incorporation of the correct nucleotide.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18769882     DOI: 10.1007/s12033-008-9096-x

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  29 in total

Review 1.  Progress in high throughput SNP genotyping methods.

Authors:  Z Tsuchihashi; N C Dracopoli
Journal:  Pharmacogenomics J       Date:  2002       Impact factor: 3.550

2.  On/off switch mediated by Exo+ polymerases: experimental analysis for its physiological and technological implications.

Authors:  Jia Zhang; Lin-Ling Chen; Zi-Fen Guo; Cui-Ying Peng; Duan-Fang Liao; Kai Li
Journal:  J Biochem Mol Biol       Date:  2003-11-30

3.  Diastereomers of 5'-O-adenosyl 3'-O-uridyl phosphorothioate: chemical synthesis and enzymatic properties.

Authors:  P M Burgers; F Eckstein
Journal:  Biochemistry       Date:  1979-02-20       Impact factor: 3.162

4.  Chemical and structural diversity of siRNA molecules.

Authors:  Barbara Nawrot; Katarzyna Sipa
Journal:  Curr Top Med Chem       Date:  2006       Impact factor: 3.295

5.  A study of the mechanism of DNA polymerase I from Escherichia coli with diastereomeric phosphorothioate analogs of deoxyadenosine triphosphate.

Authors:  P M Burgers; F Eckstein
Journal:  J Biol Chem       Date:  1979-08-10       Impact factor: 5.157

6.  Enzymatic assignment of diastereomeric purity of stereodefined phosphorothioate oligonucleotides.

Authors:  M Koziołkiewicz; A Owczarek; E Gendaszewska
Journal:  Antisense Nucleic Acid Drug Dev       Date:  1999-04

7.  Nuclease-resistant chimeric ribozymes containing deoxyribonucleotides and phosphorothioate linkages.

Authors:  T Shimayama; F Nishikawa; S Nishikawa; K Taira
Journal:  Nucleic Acids Res       Date:  1993-06-11       Impact factor: 16.971

8.  Stability of stereoregular oligo(nucleoside phosphorothioate)s in human plasma: diastereoselectivity of plasma 3'-exonuclease.

Authors:  M Koziołkiewicz; M Wójcik; A Kobylańska; B Karwowski; B Rebowska; P Guga; W J Stec
Journal:  Antisense Nucleic Acid Drug Dev       Date:  1997-02

9.  Pharmacokinetics of a potential human cytomegalovirus therapeutic, a phosphorothioate oligonucleotide, after intravitreal injection in the rabbit.

Authors:  J M Leeds; S P Henry; L Truong; A Zutshi; A A Levin; D Kornbrust
Journal:  Drug Metab Dispos       Date:  1997-08       Impact factor: 3.922

10.  Template-prime-dependent turnover of (Sp)-dATP alpha S by T4 DNA polymerase. The stereochemistry of the associated 3' goes to 5'-exonuclease.

Authors:  A Gupta; C DeBrosse; S J Benkovic
Journal:  J Biol Chem       Date:  1982-07-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.